The fight against acute leukemia has taken a monumental leap forward with the U.S. Food and Drug Administration’s (FDA) approval of Revumenib (Revuforj)—a first-in-class treatment. ... Read More
A breast cancer diagnosis can feel like an uphill battle—both emotionally and physically. For many patients and survivors, the journey ...... ... Read More
Alzheimer’s disease, a debilitating neurodegenerative disorder, affects over 50 million people globally and poses an enormous challenge for individuals, families, and healthcare systems ... Read More